Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
Status:
Active, not recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This study consists of three parts, whereas Part 1 and Part 2 are performed in Germany only,
and Part 3 is a multinational trial.
All patients with suspicion of advanced ovarian cancer are detected in the participating
study centers in a pre-screening. The study centers will register all patients with suspected
ovarian cancer in a screening log. After the patients have given informed consent, they can
be enrolled in different parts of the study.
TRUST-Trial: This part compares two strategies in the therapy of advanced ovarian cancer. En
detail, this part of the trial will evaluate if one of two strategies of timing surgery
within the therapeutic procedures may show any significant advances in terms of overall
survival over the other.